Endocrinology News

Women who sleep less than 7 hours per night during pregnancy may be more likely to have a boy with neurodevelopmental delays, according to data published in The Journal of Clinical Endocrinology & Metabolism.

Adults with type 2 diabetes and opioid use disorder who received semaglutide had significantly lower risk for opioid overdose compared with those taking other diabetes medications, a research letter in JAMA Network Open showed.

Changes in body composition may correlate with bone mineral density fluctuations in non-dialysis-dependent chronic kidney disease, according to a cohort study.

Semaglutide was shown to reduce hidradenitis suppurativa flares in patients with obesity, according to a study presented at the European Academy of Dermatology and Venereology meeting.

Women with obesity and atherosclerotic CVD without diabetes experience fewer CV events vs. men enrolled in the SELECT trial; however, semaglutide was linked to significant reductions in CV events regardless of sex, a speaker reported.

Adults with primary aldosteronism had improvements in disease severity after undergoing an adrenalectomy, according to findings published in Endocrine Practice.

The use of sodium-glucose cotransporter 2 inhibitors reduced the risk for multiple neurodegenerative diseases in adults with type 2 diabetes, according to study results published in Neurology.

Physicians can use social media to combat medical misinformation that spreads through it, according to a speaker at the Osteopathic Medical Education Conference.

Adolescent and young adult women who had prediabetes before becoming pregnant had a higher risk for gestational diabetes and adverse maternal outcomes than those with normal glycemic levels, researchers reported.

SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy, researchers reported.